Physician profile
Malvinderjit Singh
NPI 1730143165
$2,215.58
in general payments reported to CMS, 2019-2025
20 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $56.83 · 2021: $284 · 2022: $268 · 2023: $340 · 2024: $352 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013 · Education: $76.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.95 |
| Education | $76.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $555.36 | 2021-2025 | Stelara, Tremfya, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $407.06 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $215.82 | 2020-2025 | Entyvio |
| Pfizer INC. | $192.13 | 2021-2025 | |
| Tesaro, INC. | $124.99 | 2019 | |
| Covidien Lp | $120.49 | 2019-2020 | |
| Madrigal Pharmaceuticals | $101.37 | 2025 | Rezdiffra |
| Abbvie INC. | $97.37 | 2022-2024 | Mavyret |
| Intercept Pharmaceuticals, INC. | $58.58 | 2022-2023 | Ocaliva |
| Shionogi INC | $58.13 | 2019 | |
| Alnylam Pharmaceuticals INC. | $55.18 | 2023 | Givlaari |
| Olympus America INC. | $42.91 | 2023-2024 | Disposable Biopsy Forceps, Endoclot Phs |
| Aimmune Therapeutics, INC. | $35.72 | 2025 | Vowst |
| Celgene Corporation | $31.52 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $29.70 | 2025 | Iqirvo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.32 | 2021 | |
| Gilead Sciences, INC. | $19.23 | 2025 | |
| Nestle Healthcare Nutrition INC. | $16.62 | 2022 | |
| Digestive Care, INC. | $16.21 | 2022 | |
| W. L. Gore & Associates, INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malvinderjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.